Kezar Life Sciences, Inc. - stock earnings
KZR Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
Aug. 8, 2024 BeforeMarket | - / - | - | - / 600000 | 3.0 million |
KZR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2024Q1 | -21.7 million USD | ? USD |
2023Q4 | -32.3 million USD | -5.4 million USD |
2023Q3 | -23.1 million USD | 7.0 million USD |
2023Q2 | -24.3 million USD | ? USD |
2023Q1 | -20.2 million USD | ? USD |
2022Q4 | -16.3 million USD | ? USD |
2022Q3 | -16.8 million USD | ? USD |
2022Q2 | -16.1 million USD | ? USD |
2022Q1 | -16.2 million USD | ? USD |
2021Q4 | -14.2 million USD | ? USD |
2021Q3 | -14.5 million USD | ? USD |
2021Q2 | -13.0 million USD | ? USD |
2021Q1 | -13.0 million USD | ? USD |
2020Q4 | -10.9 million USD | ? USD |
2020Q3 | -11.3 million USD | ? USD |
2020Q2 | -9.5 million USD | ? USD |
2020Q1 | -10.0 million USD | ? USD |
2019Q4 | -9.6 million USD | ? USD |
2019Q3 | -9.1 million USD | ? USD |
2019Q2 | -8.7 million USD | ? USD |
2019Q1 | -7.6 million USD | ? USD |
2018Q4 | -5.8 million USD | ? USD |
2018Q3 | -5.7 million USD | ? USD |
2018Q2 | -6.8 million USD | ? USD |
2018Q1 | -4.9 million USD | ? USD |
2017Q4 | -2.3 million USD | ? USD |
2017Q3 | -2.1 million USD | ? USD |
2017Q2 | -1.9 million USD | ? USD |
2017Q1 | -2.3 million USD | ? USD |
2016Q4 | -9.0 million USD | ? USD |
KZR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -101.9 million USD | 7.0 million USD |
2022 | -65.3 million USD | ? USD |
2021 | -53.3 million USD | ? USD |
2020 | -39.0 million USD | ? USD |
2019 | -31.5 million USD | ? USD |
2018 | -23.2 million USD | ? USD |
2017 | -8.5 million USD | ? USD |
2016 | -9.0 million USD | ? USD |
KZR
Price: $0.77
52 week price:
Earnings Per Share: -1.40 USD
P/E Ratio: -0.79
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 409400
Market Capitalization: 56.2 million